Linking the response of endocrine regulated genes to adverse effects on sex differentiation improves comprehension of aromatase inhibition in a Fish Sexual Development Test  by Muth-Köhne, Elke et al.
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The  Fish  Sexual  Development  Test  (FSDT)  is a non-reproductive  test  to  assess  adverse  effects  of  endocrine
disrupting  chemicals.  With  the  present  study  it was  intended  to  evaluate  whether  gene  expression  end-
points  would  serve  as  predictive  markers  of  endocrine  disruption  in  a FSDT.  For  proof-of-concept,  a FSDT
according  to the  OECD  TG 234  was  conducted  with  the  non-steroidal  aromatase  inhibitor  fadrozole  (test
concentrations:  10 g/L, 32  g/L,  100  g/L) using  zebraﬁsh  (Danio  rerio).  Gene  expression  analyses  using
quantitative  RT-PCR  were  included  at 48  h, 96  h,  28  days  and  63  days  post  fertilization  (hpf,  dpf).  The
selection  of genes  aimed  at ﬁnding  molecular  endpoints  which  could  be directly  linked  to  the  adverse
apical  effects  of  aromatase  inhibition.  The  most  prominent  effects  of  fadrozole  exposure  on the  sexual
development  of  zebraﬁsh  were  a complete  sex  ratio  shift  towards  males  and  an acceleration  of gonad
maturation  already  at  low  fadrozole  concentrations  (10 g/L).  Due  to the  speciﬁc  inhibition  of  the  aro-
matase  enzyme  (Cyp19)  by  fadrozole  and thus,  the conversion  of  C19-androgens  to  C18-estrogens,  the
steroid  hormone  balance  controlling  the  sex ratio  of  zebraﬁsh  was altered.  The  resulting  key event is  the
regulation  of  directly  estrogen-responsive  genes.  Subsequently,  gene  expression  of vitellogenin  1 (vtg1)
and of the  aromatase  cyp19a1b  isoform  (cyp19a1b),  were  down-regulated  upon  fadrozole  treatment  com-
pared to  controls.  For example,  mRNA  levels  of vtg1  were  down-regulated  compared  to  the  controls  as
early as  48  hpf  and 96 hpf. Further  regulated  genes  cumulated  in  pathways  suggested  to  be controlled
by  endocrine  mechanisms,  like  the steroid  and  terpenoid  synthesis  pathway  (e.g.  mevalonate  (diphospho)
decarboxylase  (mvd),  lanosterol  synthase  (2,3-oxidosqualene-lanosterol  cyclase;  lss), methylsterol  monooxy-
genase  1  (sc4mol))  and  in  lipid transport/metabolic  processes  (steroidogenic  acute  regulatory  protein  (star),
apolipoprotein  Eb (apoEb)).  Taken  together,  this  study  demonstrated  that  the existing  Adverse  Outcome
Pathway  (AOP)  for aromatase  inhibition  in  ﬁsh  can  be translated  to  the  life-stage  of  sexual  differentia-
tion.  We  were  further  able  to identify  MoA-speciﬁc  marker  gene  expression  which  can  be  instrumental
in  deﬁning  new  measurable  key events  (KE) of existing  or new  AOPs  related  to endocrine  disruption.
© 2016  The  Author(s).  Published  by Elsevier  B.V.  This  is  an  open  access  article  under  the  CC. IntroductionEnvironmental pollutants which interact with the endocrine
ystem of organisms, and exert a negative impact on devel-
pment and reproduction, are commonly known as endocrine
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disrupting chemicals (EDC). Endocrine disruption manifests in
an organism or a population after sub-acute to chronic (long-
term) exposure, which makes the experimental identiﬁcation
of hormone-active substances time- and cost-intensive. These
elaborative experiments require large numbers of animals, and
alternatives approaches according to the principles of the 3R
(Replacement, Reduction, and Reﬁnement) after Russell and Burch
(1959), are highly desired. Shorter, life-stage conﬁned tests were
designed as screening tools to trigger more complex studies like
a ﬁsh life cycle test, which are required to assess the endocrine
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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isruption relevant apical endpoints. These shorter and less ﬁsh
onsuming predictive tests have, in principal, the potential to
educe the number of long-term apical tests. However, apical effect
ata from screening assays could not be used for regulatory pur-
oses.
Most life-stage conﬁned tests like the Fish Early Life Stage Test,
FELS; OECD TG 210 (OECD, 2013)) are not designed to provide
ubstantive information about the chemical mode-of-action (MoA;
illeneuve et al., 2014) and are prone to interpretation error, as
hey exclude relevant apical endpoints, like the determination of
he sex ratio. It seems therefore logical to include quick responding
arameters which may  also be indicative of the underlying MoA  or
inpoint the molecular initiating event (MIE).
Molecular endpoints respond promptly to pollutants and
romise to provide information indicative of adverse effects at
rganism level (Piersma, 2006). Powerful genomic approaches have
ontributed essentially to the determination of molecular mecha-
isms resulting in apical adverse endpoints (Ankley et al., 2006;
awle et al., 2010). Global transcriptomics allow meaningful anal-
ses of adverse effects in cells, organs, and the whole organism at
oncentrations potentially below thresholds of the most sensitive
ndpoints of the “conventional” studies. This higher sensitivity of
olecular analyses is crucial to prevent the overlay of endocrine
ffects by other effects, especially systemic toxicity (Scholz and
ayer, 2008; Wang et al., 2010). The progress in molecular and
omputer-based (in silico) methods paved the way  for the shift
f paradigms in ecotoxicology (NRC, 2007), and for the develop-
ent of causal mechanism-based concepts for environmental risk
ssessment, e.g. the Toxicity Pathways (Bradbury et al., 2004) or
ore recently the Adverse Outcome Pathways (AOPs; Ankley et al.,
010; Villeneuve and Garcia-Reyero, 2011). Speciﬁc AOPs aim to
rovide causal links between the MIE  and the adverse outcome (AO)
f regulatory concern via well-established, measureable key events
KEs) and key event relationships (KERs), which are intended to
acilitate regulatory decision making (Kramer et al., 2011; Segner,
011, 2009). To date several AOPs have already been deﬁned for
ndocrine disruption (aopkb.org/aopwiki). However, the AOP for
romatase inhibition is only applicable to sexually mature female
sh, as the AO at the organism level is reduced fecundity (Ankley
t al., 2010, 2009; aopkb.org/aopwiki/index.php/Aop:25), and no
easureable KE is described at the molecular level.
Zebraﬁsh are particularly sensitive to aromatase inhibitors dur-
ng gonadal sex differentiation and maturation, the phase between
he early life stage and adulthood (Baumann et al., 2015, 2013;
enske and Segner, 2004; Kinnberg et al., 2007). As undifferentiated
onochorists, zebraﬁsh’ gonads develop via a stage described as
on-functional protogyne gonad (Maack and Segner, 2003). Testis
ifferentiation and male maturation are triggered by increasing lev-
ls of androgens, while maturation of ovaries requires higher levels
f estrogens. Aromatase inhibitors block the synthesis of estrogens
y inhibition of the conversion of C19-androgens to C18-estrogens
Callard et al., 1978). The surplus of androgens consequently favors
asculinization in the population (Baumann et al., 2015, 2013;
enske and Segner, 2004; Morthorst et al., 2010; Trant et al., 2001).
The Fish Sexual Development Test (FSDT; OECD TG 234, OECD,
011) allows the analysis of effects of endocrine disruptors on the
arly life stage and sexual development. The FSDT is essentially an
xtension of the FELS test. It was originally developed as a “Fish Par-
ial Life Cycle Test” and considered an alternative to speciﬁcally test
ndocrine disruptors in ﬁsh without the requirement of a whole
ife span exposure. It covers the endocrine disruption prone devel-
pmental period of sexual differentiation of particularly zebraﬁsh
nd allows the assessment of gonadal differentiation and sex ratio
s endocrine disruption-associated endpoints (Thorpe et al., 2011).
owever, the information on the endocrine system functions whichcology 176 (2016) 116–127 117
is being disrupted is limited to EDCs affecting vitellogenin and the
phenotypic gonadal sex ratio.
The conceptual framework of the OECD for Testing and Assess-
ment of Endocrine Disruptors (OECD, 2012a) is mainly focused on
the assessment of chemicals disrupting estrogen, androgen, thy-
roid signaling processes and steroidogenesis (EATS), but there are
several other endocrine pathways (e.g. corticosteroid, gestagenic,
or retinoid signaling pathways), which additionally may be dis-
rupted by chemical exposure. The use of additional new endpoints
may  help in better understanding the link between the initiating
endocrine related mechanisms and resulting apical effects. This
would strengthen an AOP-driven approach in the context of the
weight-of-evidence strategy that is currently pursued in the reg-
ulatory context to assess an endocrine disruption hazard (OECD,
2012b). The need for more comprehensive methods has been
acknowledged and highlighted in the Review paper of the OECD
on Novel In Vitro and In Vivo Screening and Testing Methods and
Endpoints for Evaluating Endocrine Disruptors (Kortenkamp et al.,
2011; OECD, 2012b).
The rationale of the current study was to demonstrate that gene
expression data could help to increase the evidence on whether and
how a substance may  act as an EDC. To this end, an FSDT accord-
ing to the OECD guideline 234 was  conducted with the aromatase
inhibitor fadrozole and reﬁned by mRNA analysis using quantita-
tive RT-PCR. The rationale to choose fadrozole as test substance is
that its endocrine disrupting effects are reasonably well deﬁned for
ﬁsh (Afonso et al., 2000; Ankley et al., 2002; Fenske and Segner,
2004; Scholz and Klüver, 2009; Takatsu et al., 2013; Villeneuve
et al., 2013; Wang et al., 2010; Zhang et al., 2008). Fadrozole is
a potent, selective non-steroid aromatase inhibitor. Although its
interaction with the enzyme is not yet fully understood, coordina-
tion with the iron of the prophyrine core of the CYP19 enzyme is
likely. This describes a characteristic general function of type-II-
inhibitors, which was  ﬁrst described in mammals (Browne et al.,
1991). Fadrozole therefore exhibits a speciﬁc aromatase-inhibiting
MoA  with fewer side effects than e.g. prochloraz, which inhibits
steroidogenesis as well as androgen receptor signaling (Ankley
et al., 2005; Laier et al., 2006).
In this study, a set of endocrine-related genes was  measured in
early life stages, and in juvenile and pre-adult ﬁsh at the end of
the test, in addition to the default endpoints of the FSDT (hatch,
juvenile growth, sex ratio, plasma vitellogenin, and histopathol-
ogy). The selection of potential marker genes was based on previous
results of our own and published studies (Schiller et al., 2013a,
2013b; Villeneuve et al., 2009), which indicated their sensitivity
to endocrine disruption and especially aromatase inhibition. The
group of selected genes covers also several critical steps in steroid
biosynthesis.
Taken together, this study demonstrated that the existing
Adverse Outcome Pathway (AOP) for aromatase inhibition in ﬁsh
can be translated to the life stage of sexual differentiation. Fur-
ther, we were able to identify marker gene transcription involved
in steroid biosynthesis which can be applied as measures of key
events (KE) at the molecular level.
2. Material and methods
2.1. Test species
Wild-type zebraﬁsh (Danio rerio) originally obtained from West
Aquarium GmbH (Bad Lauterberg, Germany) and continuously bred
for several generations in the Fraunhofer IME  laboratories, were
used for testing. Zebraﬁsh of this line correspond in their juve-
nile/sexual development to the line described by Takahashi (1977)
and Maack and Segner (2003).
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Fish of the broodstock were maintained under ﬂow-through
onditions in 150 L tanks at 25 ± 2 ◦C on a 12:12-h photoperiod in a
emperature-controlled room. They were fed daily with TetraMin®
ain feed ad libitum and nauplii of Artemia salina.
For egg collection, stainless steel spawning trays were inserted
nto the tanks, and spawning was induced at the beginning of the
ight period (light intensity: 1000 lux). The eggs were microscopi-
ally examined for fertilization success. Only healthy eggs in at least
lastula stage were inserted into the test system.
.2. Test substance
Fadrozole (IUPAC-Name 4-(5,6,7,8-Tetrahydroimidazo[1,5-
]pyridine-5-yl)-benzonitrile), an aromatase inhibitor, was
urchased from Adooq Bioscience LLC. (Irvine, Canada). The sub-
tance was directly dissolved in water for the preparation of the
osing solutions.
.3. General exposure conditions
Puriﬁed tap water was used according to the OECD-Guideline
10 (OECD, 2013). The puriﬁcation included ﬁltration with acti-
ated charcoal. The water was aerated to the level of oxygen
aturation. The water quality was monitored in the testing facility.
Water temperature in the test vessels was adjusted to 25 ± 2 ◦C.
xygen saturation of the test solutions was between 99.0% and
03.4% of air saturation. The pH was between 8.08 and 8.17 in the
est tanks.
.4. Assessment of Fish Sexual Development test (OECD TG 234)
ndpoints
The Fish Sexual Development Test (FSDT) was  performed
ccording to the OECD Test Guideline 234 (OECD, 2011) in a ﬂow-
hrough exposure system. Minor modiﬁcations of the protocol were
ecessary to include gene expression analysis at different time
oints.
The test was performed with three test concentrations (10 g/L,
2 g/L, and 100 g/L.) under ﬂow through conditions, with four
eplicate tanks per concentration run in parallel. A number of 85
ggs per replicate tank (12 L total volume) were introduced at test
tart divided into two stainless steel fry cages. One fry cage of 50
ggs provided samples for the gene expression analysis, the other
ry cage of 35 eggs remained undisturbed.
The eggs were kept in the fry cages until hatching and the
umber of hatched larvae was estimated at 4 and 6 days post fer-
ilization (dpf). At 21 dpf, larvae were released from both fry cages
nto the main tank. After the early life stage at 28 dpf, the juvenile
sh were photographed for image-based evaluation of survival and
rowth (ImageTool of the University of Texas Health Science Center
t San Antonio, Version 3.0). Fish remained in the test system until
est termination at 63 dpf. At test termination, survival rate, size in
erms of length and weight, and the sex of all ﬁsh were determined.
wenty ﬁsh per replicate were analyzed for their vitellogenin (VTG)
ontent, and were histopathologically evaluated.
For gene expression analysis, 20 embryos of 48 and 96 h post
ertilization (hpf) were sampled from each replicate, pooled in a
.5 mL  Eppendorf tube and snap frozen. At 28 dpf, 4 randomly cho-
en larvae per replicate were pooled and snap frozen in a 2.0 mL
ppendorf tube; at test termination, the trunks of 5 ﬁsh per repli-
ate (heads removed) were randomly chosen for gene expression
nalysis and snap frozen individually. The heads were removed in
rder to focus on endocrine effects related to gonad development.
ll samples were stored at −80 ◦C until further use.
For histopathology and VTG measurements, blood samples were
ollected (by cardiac puncture) and gonads dissected from allcology 176 (2016) 116–127
ﬁsh except those dedicated to gene expression analysis. Gonads
were incubated in modiﬁed Davidsons’s ﬁxative 20% formalde-
hyde (37%), 10% glycerol, 30% ethanol, and 10% acetic acid (100%)
overnight, then transferred to 10% neutral buffered formalin
(according to the OECD Histopathology guidance document (OECD,
2010)). Embedding was  performed with parafﬁn and trunks orien-
tated ventrally to the cutting surface. Sections of 4–5 m were cut
with a microtome, mounted on glass slides and then stained with
hematoxylin-eosin.
Microscopic evaluation of the tissue sections was performed
according to the OECD Histopathology Guidance Document (OECD
2010). Each ﬁsh was either sexed or recorded as undifferenti-
ated and the maturation stage of the gonads were categorized.
Endocrine-related effects were determined according to the pri-
mary and secondary diagnostic evaluation criteria.
For determination of the VTG levels, an enzyme-linked
immunosorbent assay (ELISA) for zebraﬁsh VTG (homologous ELISA
kit, Biosense, Bergen, Norway) was used according to the manu-
facturers’ instructions. Plasma samples were measured in 96-well
plates by a microplate reader (iEMS Reader, Labsystems, Helsinki,
Finland). The assay was  calibrated against puriﬁed zebraﬁsh VTG
(provided with the kit) as a standard. A blank control was  run in
each assay. The VTG concentrations were normalized to the total
plasma protein content, and data expressed as ng VTG/g pro-
tein (Fenske et al., 2001). Total protein was  quantiﬁed using a BCA
Protein Assay Reagent Kit (Pierce, Rockford, USA).
2.5. Quantitative RT- PCR (QPCR)
Total RNA was isolated from homogenized frozen trunk tis-
sue (63 dpf) or pooled embryos/larvae/juveniles using TRIreagent
(Sigma-Aldrich, T9424) method followed by a clean-up with
RNeasy Mini Spin Columns (QIAGEN, Hilden, Germany) according
to the manufacturers’ protocols. Prior to cDNA synthesis, RNA was
DNAse (Sigma-Aldrich, AMP-D1) treated and subsequently mea-
sured using a NanoDrop 1000 spectrophotometer (Thermo Fisher
Scientiﬁc, Schwerte, Germany). Reverse transcription was car-
ried out using SuperScriptTM III Reverse Transcriptase (Invitrogen,
Carlsbad, USA). Negative controls without reverse transcriptase
were prepared for each sample.
QPCR analysis was performed on three of four replicates of
each treatment (fadrozole exposures and controls) at each sam-
pling time point, using a BioRad iQ5 real-time PCR detection
system (BioRadTM, Hercules, USA). The fourth replicate samples
were excluded from the analysis due to RNA quality issues. For each
reaction, 40 ng of cDNA were added to Sybr®Green qPCR Super Mix
(ThermoFisher Scientiﬁc/Invitrogen, Waltham, USA) in white 96-
well PCR plates. Two technical replicates of each target gene and
the respective reference genes were run for each cDNA sample.
Minus template controls were included on each plate; minus RT
controls were included repeatedly, at least once for each sample,
however not in every run. The reference genes 18s and rpl8 were
used to normalize the expression values of the target genes.
The PCR protocol was as follows: After incubating for 2 min
at 50 ◦C and for 10 min  at 95 ◦C (for DNA polymerase activation),
targets were ampliﬁed using the following cycle: 95 ◦C for 15 s,
then 54, 54.5 or 60 ◦C for 30 s (annealing temperatures for par-
ticular genes) and 60 ◦C for 30 s (for acquisition; 40 cycles); the
run was  ﬁnalized by a melting curve analysis: 95 ◦C for 60 s, then
55 ◦C for 60 s (80 cycles, with +0.5 ◦C increment each cycle and a
10 s acquisition). Relative gene expression ratios were calculated
by the comparative delta Ct method (ddCt) (Livak and Schmittgen,
2001; Pfafﬂ, 2001).
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.6. Chemical water analysis
Water samples of 10 mL  volume were taken from each tank from
he mid  water body, at test start, and thereafter once a week. The
amples were taken alternating from one of the two  test vessels
erved by one dosing pump. Water samples were stabilized by addi-
ion of acetonitrile (1:1; v + v) containing 0.2% formic acid prior to
torage.
Fadrozole analysis was performed by high performance liq-
id chromatography tandem mass spectrometry (LC–MS/MS)
ith negative ionization. Data were collected on a Waters 2695
eparations module coupled to a Quattro-Micro tandem mass spec-
rometer (Waters). Aliquots of 50 L were injected into a Gemini
18 high-performance LC column (150 mm × 3 mm,  5 m parti-
le size; Phenomenex) at a ﬂow rate of 0.5 mL/min and a column
emperature of 30 ◦C. Matrix-free procedural blanks were run each
orking day to exclude possible cross-contaminations during lab-
ratory work. Separation was performed on a binary gradient of
0 mmol  ammonium acetate solution in (A) methanol and (B) a
0:10 water:methanol mixture. The gradient started with 60% A,
ncreasing to 100% A within 3 min, then returning to 60% A and 40%
 after 6.1 min, and holding initial conditions for 3 min. A Calibra-
ion was performed in a concentration range of 0 g/L to 250 g/L
adrozole. Coefﬁcient of correlation (r2) of the calibration function
as estimated ≥ 0.99. The substance-speciﬁc limit of quantitation
LOQ) was deﬁned as 5 g/L fadrozole.
.7. Statistical analysis
All physiological endpoints as well as the sex ratio were ana-
yzed using ToxRat® Professional 3. Normal distribution of data
as conﬁrmed by the Shapiro-Wilks test, followed by Levene’s
est for variance homogeneity. A one-way ANOVA was performed,
ith the Williams t-test as post-hoc test, applying a signiﬁcance
evel of p ≤ 0.05. Data on gonad histopathology were evaluated
ith GraphPad Prism (GraphPad Software, La Jolla, USA) including
ne-way ANOVA followed by Dunnett’s multiple t-test procedure,
 ≤ 0.05. For the biological results, No Observed Effect Concentra-
ions (NOEC) and Lowest Observed Effect Concentrations (LOEC)
ere determined.
For gene expression, the statistical determination of signif-
cant differences of the fadrozole treatments compared to the
ontrols, one-way ANOVAs followed by Dunnett’s multiple com-
arison test (*p < 0.05; **p < 0.01; ***p < 0.01), or Students t-test
*p < 0.05; **p < 0.01; ***p < 0.01), were performed on relative tran-
cript expression values of the three replicates. Control-normalized
ata were log2-transformed for presentation.
. Results
.1. Chemical analysis
The mean measured concentrations of the test solutions of
adrozole between day 1 and day 61 of the study ranged between
4.4% and 114.8% of nominal concentration per treatment (Table
2). Test concentrations during the time course of the study did
ot vary by more than 20% from nominal concentrations for most
essels with few exceptions (maximum concentration of 147.7% of
ominal at a nominal concentration of 32 g/L). All effect data are
epicted according to the nominal fadrozole concentrations.
.2. Effects of fadrozole on the FSDT standard endpointsThe hatching success of larvae was not inﬂuenced by fadrozole.
omplete hatch was observed at 6 dpf in controls as well as in
reatments. Survival during early life, however, was diminished incology 176 (2016) 116–127 119
a concentration-dependent manner. Post-hatch survival rates at 28
dpf were 80.6% and 77.8% for control respectively the 10 g/L fadro-
zole treatment, with controls meeting the validity criterion of 75%
post-hatch survival recommended by the TG 234 (OECD, 2011). The
28 dpf post-hatch survival rates of the 32 g/L and 100 g/L treat-
ment decreased signiﬁcantly to 70.6% and 67.8% (Fig. 1A; *p < 0.05,
Williams t-test, one-sided smaller). The NOEC for post-hatch sur-
vival was determined to be at 10 g/L fadrozole. Survival was  not
further affected by fadrozole at 63 dpf.
Growth in terms of mean total body length at 28 dpf and in terms
of mean standard length and wiped wet weight at 63 dpf was found
not to be affected by fadrozole. At 28 dpf, the average length of
the control ﬁsh was 10.1 mm whereas the treatment lengths varied
between 10.6 mm (100 g/L) and 10.7 mm (at 10 g/L and 32 g/L).
Thus, no signiﬁcant difference between the control and exposed
28 dpf ﬁsh was observed. The mean body length of 63 dpf control
and exposed ﬁsh was 28.0 mm.  The mean weight increased slightly
with increasing exposure concentration, from 0.183 g for the con-
trols to 0.196 g in the highest treatment condition. However, the
differences in the mean values were not signiﬁcant.
3.3. Histopathology and sex ratio
Gonadal sex ratios were determined during the histopatho-
logical evaluation. The controls displayed a mean proportional
ratio of males to females of 49.9–50.1% across all replicates. In
all fadrozole treatments, the sex ratios were signiﬁcantly differ-
ent from the controls (Fig. 1B; p < 0.05, Williams t-test, two-sided,
data arcsine-transformed prior to statistical analysis). At the low-
est concentration, all ﬁsh were males, except for one female in one
replicate. At the higher concentrations, only males were identiﬁed.
As no females were present in the treatment groups,
histopathology of ovaries was limited to controls. The ovarian
development of the control ﬁsh was  characterized by gonads con-
sisting of early stage oocytes. Only one gonad had reached a
maturation stage of 2, all other ovaries were at stage 0 or 1. Accord-
ing to the maturity index of Baumann et al. (2013), this early ovary
maturation stage corresponded to a maturity index of 1.8. The ovar-
ian maturation of the remaining single female at 10 g/L fadrozole
corresponded to a maturity stage of 0 (maturity index of 1). The
delay in ovarian maturation was  not associated with any patholog-
ical alterations of the gonads.
Males of the control groups had an average testis maturity index
of 2.1. The average gonad maturity of males increased with increas-
ing fadrozole concentrations (Fig. 1C) and became statistically
signiﬁcant already from 10 g fadrozole/L (**p < 0.01, ***p < 0.01;
one-way ANOVA followed by Dunnett’s multiple comparison test).
At 100 g fadrozole/L the highest average maturity index reached
2.7.
The gonads of control males were found to be in an undeveloped
protogynous state at 38.2 %. This state marks the transition phase
from an ovary-like structure to the male testis, which is a typical
phase in zebraﬁsh sexual development (Maack and Segner, 2003).
The incidence of the undeveloped gonad stage remained below
20% in all fadrozole exposed ﬁsh (statistically no difference to the
control) (Fig. 1D), consistent with the increasing gonad maturity
indices of the treatment groups.
3.4. Vitellogenin measurement
VTG plasma concentration analysis was performed in pre-
adult development (i.e., 63 dpf). The plasma concentrations of
the control females displayed high variation but were on average
12.18 ng VTG/g protein. Females with low amounts in the range
≤0.01 ng/g were also found.
120 E. Muth-Köhne et al. / Aquatic Toxicology 176 (2016) 116–127
Fig. 1. Physiological and histopathological effects of fadrozole exposure. (A) Post-hatch survival (depicted as% of hatched larvae at 6 dpf) of 28 dpf zebraﬁsh was signiﬁcantly
reduced at nominal 32 g/L and 100 g/L fadrozole compared to control ﬁsh (white bar). (B) Sex ratio at 63 dpf (depicted as% males versus females) was fully skewed towards
males  at all fadrozole concentrations. (C) The gonad maturation stage of 63 dpf males, represented by the maturity index (Baumann et al., 2013), increased signiﬁcantly
f ic stage) gonads after fadrozole treatment. Statistical differences were determined by
W  with Dunnett’s multiple comparison test, *p < 0.05; **p < 0.01; ***p < 0.001 (C–D); n = 4
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Fig. 2. Signiﬁcantly changed genes in embryo (48 hpf) and larval stage (96 hpf)
zebraﬁsh, after exposure to fadrozole at nominal 10 g/L (light grey bars) 32 g/L
(medium grey bars) and 100 g/L (dark grey bars). Bars depict log2-fold-changes
versus the control mRNA levels. (A) At 48 hpf, mvd and igf1 were signiﬁcantly up-
regulated and vtg1 was  down-regulated. (B) At 96 hpf, lss,  vtg1, esr2a, gnrhr2, gnrhr3,
were down-regulated and igf1, sox9b, and zgc:64022 up-regulated. Statistical differ-
ences of reference-normalized mean transcription values of treatments to control
values (Livak and Schmittgen, 2001; Pfafﬂ, 2001) were determined by one-wayrom  10 g/L fadrozole. (D) Ratio of males (%) displaying undeveloped (protogyn
illiams t-test, one-sided smaller, with *p < 0.05 (A–B), and by one-way ANOVA,
amples/treatment.
Male ﬁsh displayed VTG concentrations below or close to the
OD. A tendency to lower concentrations in treatment conditions
han in the controls was observed but was not quantiﬁable. Effects
f fadrozole on VTG plasma concentrations of females could not
e determined with only one single female found in one replicate
f the 10 g fadrozole/L treatment. This female displayed a VTG
oncentration of 0.01 ng VTG/g protein, which was lower by a
actor of 1000 than the mean VTG concentration found in control
emales.
.5. Effects of fadrozole on gene expression
Twenty-eight target genes involved in steroid hormone biosyn-
hesis and signaling (Table S1) were analyzed by qPCR. MRNA levels
f these genes were assessed for all sampling time points, calcu-
ating the log2-fold changes compared to the respective controls.
esults are only shown for the most signiﬁcantly changed genes
Fig. 2 and Fig. 3).
At the end of embryogenesis (48 hpf), 21 of the 28 selected target
enes were found to be expressed. No expression could be detected
or neuropeptide Y1 receptor (npy1r), gonadotropin-releasing hor-
one receptor 1, 2 and 3 (gnrhr1, gnrhr2,  gnrhr3), insulin-like growth
actor binding protein 5a (igfbp5a), prospero homeobox 1 (prox1), and
romatase a (cyp19a1a)  (Fig. 4). Statistically signiﬁcant differences
etween controls and fadrozole treatments were observed for
evalonate (diphospho) decarboxylase (mvd), vitellogenin 1 (vtg1),
nd insulin-like growth factor 1 (igf1). MRNA levels of mvd and
gf1 was found to be up-regulated up to log2-fold changes of 2,
hile vtg1 was found to be down-regulated with log2-fold changes
etween 0 and −1 (Fig. 2A). These differences were statistically
igniﬁcant (*p < 0.05) at 10 g/L fadrozole for mvd and vtg1, andANOVA with Dunnett’s multiple comparison test, and by Students t-test; *p < 0.05;
**p  < 0.01; ***p < 0.001; n = 3 replicates/treatment. Control-normalized data were
log2-transformed prior to presentation.
at 32 g/L fadrozole for igf1, and highly signiﬁcant (**p < 0.01) at
32 g/L fadrozole for mvd.
At the larval stage of 96 hpf, 26 genes were found to be expressed
and signiﬁcant differences compared to the control values were
observed for eight genes. No expression was observed for gnrhr1,
and follicle stimulating hormone receptor (fshr) (Fig. 4). The genes
igf1, SRY (sex determining region Y)-box 9b (sox9b), and zgc:64022
were fadrozole concentration-dependently up-regulated, with
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Fig. 3. MRNA levels in pre-adult zebraﬁsh at 63 dpf. (A) Divergence in the relative vtg1 mRNA amounts in control zebraﬁsh: Five ﬁsh out of two control replicates displayed
high  vtg1 mRNA and ten ﬁsh out of three control replicates low vtg1 mRNA. Accordingly, the control ﬁsh were divided into 5 high and 10 low vtg1 expressers. (B) Signiﬁcant
differences in gene expression between low and high vtg1 expressers, depicted as log2-fold change. The gene esr2a, and cyp19a1b showed the same discriminating expression
levels  in control ﬁsh than vtg1. (C + D) Signiﬁcantly changed gene transcripts in fadrozole exposed zebraﬁsh (10 g/L: light grey bars; 32 g/L: medium grey bars; 100 g/L:
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tark  grey bars) compared to (C) low vtg1 expressers (control) and (D) high vtg1 expr
f  treatments to control values (Livak and Schmittgen, 2001; Pfafﬂ, 2001) were det
-test;  *p < 0.05; **p < 0.01; ***p < 0.001; n = 5 ﬁsh/replicate; 3 replicates/treatment. 
og2-fold changes between 0.5 and up to 2. Differences for sox9b
nd zgc:64022 were signiﬁcant (*p < 0.05) at 32 g/L and for igf1
ighly signiﬁcant (**p < 0.01) at 10 g/L and most highly signiﬁ-
ant (***p < 0.001) at 32 g/L and 100 g/L (Figure 2 B). Lanostyryl
ynthase (lss), vtg1, estrogen receptor 2a (esr2a), gnrhr2,  and gnrhr3
ere down-regulated by log2-fold changes in the range of −1.
hese changes were statistically signiﬁcant (*p < 0.05) for vtg1 and
nrhr2 at 10 g/L of fadrozole, for esr2a at 32 g/L, and for gnrhr3
t 100 g/L fadrozole. Highly signiﬁcant (**p < 0.01) was  the differ-
nce for lss at 32 g/L (Fig. 2B).
The developmental stage at 28 dpf showed the lowest overall
ene response. All target transcripts were found but none expressed
t signiﬁcantly different fold-change levels. Particularly high vari-
tions were observed between replicates.
The pre-adult 63 dpf ﬁsh which were analyzed for gene expres-
ion, had not been subjected to gonadal sex determination or
istopathology. Thus, the morphological sex of these ﬁsh was
nknown. However, these ﬁsh showed divergence in the relative
RNA amounts of vtg1 in the control samples (after normaliza-
ion to the reference genes). A group of control ﬁsh exhibiting
elative vtg1 mRNA amounts of 0.00005–0.0017, separated clearly
by a factor of 500) from a high level vtg1 group with mRNA lev-
ls of 0.13–0.46 (Fig. 3A). A sex-dependent expression of the vtg1
RNA was assumed and consequently, the control ﬁsh divided into
 low and a high level vtg1 group for analysis. Accordingly, the
RNA levels of the other target genes were compared between
he “low” and “high” vtg1 expresser control groups. Twenty-ﬁve of
he 28 target genes were expressed in the controls; no transcrip- (control). Statistical differences of reference-normalized mean transcription values
ed by one-way ANOVA with Dunnett’s multiple comparison test, and by Students
l-normalized data were log2-transformed prior to presentation.
tion was  detected for kiss1 receptor a (kiss1ra), gnrhr1,  and gnrhr2.
The log2-fold change differences of low vtg1 compared to high vtg1
expressers (Fig. 3 B) were highest for vtg1 (−9.0; most highly sig-
niﬁcant, ***p < 0.001), at −0.8 for esr2a, and at −3.1 for the brain
aromatase (cyp19a1b; both signiﬁcant, *p < 0.05). Large but non-
signiﬁcant log2-fold change differences were additionally observed
for gnrhr4 (−5.8) and cyp19a1a (approx. 5.0) (Fig. 4).
Gene expression measured in the fadrozole treated ﬁsh was
compared to low as well as high vtg1 expressing controls. According
to the results of the histopathological examinations, which identi-
ﬁed 100% of fadrozole-treated ﬁsh at 63 dpf as males (compare
skewed sex ratio described in Section 3.3), no statistically diver-
gent vtg1 mRNA expression in individual treatments was observed.
Compared to the low vtg1 controls, a signiﬁcant induction was
observed for lss at 32 g/L and 100 g/L of fadrozole, and for star
and prox1 at 100 g/L (all **p < 0.01; Fig. 3C).
Compared to the high vtg1 expressers of the controls, more
genes were found to be differentially expressed in fadrozole treated
63 dpf ﬁsh. Statistically signiﬁcant differences were observed for
lss, vtg1, star, esr2a, igfbp5a, prox1, cyp19a1b, and zgc:64022.  Highly
signiﬁcantly (**p < 0.01) up-regulated was  lss at fadrozole concen-
trations of 32 g/L and 100 g/L, and still signiﬁcant (*p < 0.05) was
star, igfbp5a, and prox1 at 100 g/L. Down-regulation was  most
highly signiﬁcant (***p < 0.001) for vtg1 at all fadrozole concentra-
tions, and for esr2a at 32 g/L. Highly signiﬁcant down-regulation
was observed for esr2a at 10 g/L and 100 g/L; still signiﬁcant
was cyp19a1b and zgc:64022 at all concentrations (*p < 0.05). The
log2-fold changes ranged from −9.0 for vtg1 to 2 for lss (Fig. 3D).
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Fig. 4. Heatmap-like illustration of the log2-fold changes of all target genes in relation to control ﬁsh at the respective time points. Color and intensity reﬂect the mean log2 fold-change values of each gene at a given sampling
time  point and treatment group, with red shades representing down-regulation (negative log2-fold values) and green shades representing up-regulation (positive log2-fold values); the highest color intensity reﬂects the strongest
regulation at the given sampling time point. Light yellow denotes no regulation. White cells indicate that no transcription was detected. Asterisks (*) in the cells denote levels of signiﬁcance according to the footnote below the
table.  (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web  version of this article.)
E. Muth-Köhne et al. / Aquatic Toxicology 176 (2016) 116–127 123
Fig. 5. MRNA levels of the potential marker genes igf1, star, lss,  cyp19a1b, and vtg1 over time. (A) Average expression levels in control ﬁsh at the different analysis time points.
Data  depict relative fold-changes normalized to the mRNA level at 48 hpf. (B–F) Fadrozole-induced log2 fold- changes of igf1, star, lss,  cyp19a1b, and vtg1 compared to the
corresponding control groups at each analysis time point. Statistical differences of reference-normalized mean transcription values of treatments to control values (Livak
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 = 3 replicates/treatment (48/96 hpf, 28 dpf); n = 5 ﬁsh/replicate; 3 replicates/treatm
nterpretation of the references to colors in this ﬁgure legend, the reader is referred
As Fig. 4 illustrates, statistical analysis revealed that 13 out of the
8 target genes showed signiﬁcant regulation for at least one treat-
ent level and time point, seven genes were found to be regulated
n more than one exposure at a given time-point and ﬁve genes (lss,
tg1, esr2a, igf1, zgc:64022)  were regulated at more than one time
oint. No gene was signiﬁcantly regulated at all developmental
tages investigated. Based on the mRNA expression patterns (Fig. 4),
otential marker genes for aromatase inhibition were identiﬁed,
hich responded signiﬁcantly at least to two fadrozole exposure
oncentrations, or at two developmental stages. Accordingly, igf1,
tar, lss,  cyp19a1b, and vtg1 were selected as potential markers and
nalyzed in more detail in terms of their transcription over time
t control conditions as well as in response to fadrozole treatment
Fig. 5). At control conditions, the mRNA of lss,  igf1 and cyp19a1b multiple comparison test, and by Students t-test; *p < 0.05; **p < 0.01; ***p < 0.001;
63 dpf). Control-normalized data were log2-transformed prior to presentation. (For
e web  version of this article.)
showed a steady increase from 48 hpf to 63 dpf (Fig. 5A) whereas
star was  down-regulated at 96 hpf and 28 dpf compared to 48 hpf,
before returning to the 48 hpf level at 63 dpf. Expression of vtg1
showed a decrease below the 48 hpf level at the juvenile stage
(28 dpf) before it increased sharply in the female ﬁsh with sexual
maturation at 63 dpf. In male ﬁsh, the vtg1 mRNA was on average
slightly above the 48 hpf level. Sex related differences in mRNA lev-
els of control ﬁsh at 63 dpf were, apart from vtg1, also displayed by
cyp19a1b.
Fadrozole exposure affected the ﬁve marker genes differently
in the course of development (Fig. 5B–F). During early life, igf1
(Fig. 5B) was up-regulated at 48 hpf (signiﬁcantly at 32 g/L fadro-
zole) and at 96 hpf (signiﬁcant at all treatment levels), lss (Fig. 5D)
was down-regulated at 96 hpf at a concentration of 32 g/L, and
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tg1 (Fig. 5F) responded by up-regulation at 48 hpf (200 g/L) and
6 hpf (10 g/L). On the other hand, a response to fadrozole of star
Fig. 5C) and cyp19a1b (Fig. 5E) only occurred at 63 dpf, suggest-
ng that the reduced levels of estrogen affected the transcription
f these genes only at a later developmental stage. Most notably,
yp19a1b was down-regulated in the 63 dpf exposed ﬁsh only in
elation to the high vtg1 control group. Most importantly, vtg1
as strongly down-regulated in relation to the high vtg1 puta-
ive female controls at 63 d. This result is consistent with results of
istopathology showing that almost all fadrozole treated ﬁsh were
orphologically identiﬁed as males.
. Discussion
Alternative concepts are currently being pursued in regulatory
cotoxicology to discriminate, prioritize, and assess endocrine dis-
upting chemicals (EDCs). These concepts integrate in silico and
olecular data to better explain adverse outcomes of regulatory
oncern (Ankley et al., 2010; Bradbury et al., 2004; Meek et al., 2014;
RC, 2007; Perkins et al., 2015; Villeneuve and Garcia-Reyero,
011). The knowledge of the responses at the molecular level and
ow these responses relate to a particular adverse outcome is
nstrumental in predicting endocrine disruption more reliably and
ossibly earlier than traditionally, where only apical effect end-
oints and few physiological biomarkers are used. The aim of the
tudy was thus to investigate the value of additional molecular
ndpoints, like gene expression, for the identiﬁcation of EDCs and
otentially also the mode of endocrine action, prior to the manifes-
ation of adverse effects.
Classiﬁed as a level 4 study, the FSDT covers early developmen-
al stages as well as the phase of sexual maturation of zebraﬁsh
Maack and Segner, 2003). It therefore delivers apical and physio-
ogical data, as well as the possibility to obtain early molecular data
rom treated embryos or larvae.
During the FSDT, we observed a weak, but signiﬁcant effect on
ost-hatch survival at 28 dpf (Fig. 1A). This observation suggested
ow systemic toxicity, which could be explained by an elevated
tress susceptibility known for larval stages of ﬁsh, especially
fter chemical treatment (Belanger et al., 2010; Diekmann and
agel, 2004; Woltering, 1984). During the larval stage, the energy
etabolism changes from intrinsic nutrient absorption from the
olk to external feeding, which often results in increased mor-
ality also under control conditions. Supporting this assumption
f increased sensitivity of larval ﬁsh, zebraﬁsh embryos exposed
o even higher fadrozole concentrations (0.1–1.0 mg  fadrozole/L;
npublished results) did not display increased mortality. Generally,
actors such as systemic toxicity were proposed to inﬂuence end-
oints known as endocrine indicators in a non-endocrine manner
Wheeler et al., 2013). However, it was deemed very unlikely that
he observed effects of fadrozole on sex ratio and gonad maturation
Fig. 1B–D) in the present study were a result of systemic toxicity.
adrozole has a very speciﬁc aromatase inhibition MoA, and the
ame effects on zebraﬁsh sex ratio have already been described
lsewhere (Fenske and Segner, 2004; Takatsu et al., 2013). Accord-
ngly, we concluded that the observed effects on gene expression
ere also caused by aromatase inhibition and not by systemic tox-
city.
During development, zebraﬁsh gonads respond particularly
ensitive to aromatase modulations during the phase of gonadal
ex differentiation. They are described as undifferentiated gono-
horists, which develop via a stage described as non-functional
rotogyne gonad (Maack and Segner, 2003). This undifferentiated
onadal stage is inﬂuenced by the estrogen-to-androgen ratio dur-
ng steroid biosynthesis. An imbalanced ratio easily results in a
kewed sex ratio. Thus, treatment with an aromatase inhibitor likecology 176 (2016) 116–127
fadrozole decreases the estrogen level and consequently results
in an increased male-to-female ratio (Fenske and Segner, 2004;
Takatsu et al., 2013). Additionally, steroid biosynthesis may  be
stimulated by positive feedback regulation due to low levels of
estrogens via a loop induced. This would lead to even higher testos-
terone levels with aromatase conversion being inhibited (Ankley
and Villeneuve, 2015; Villeneuve et al., 2013, 2009). The under-
lying regulatory molecular mechanisms are not straightforward
as gene expression regulation can occur directly (e.g. via genes
possessing an estrogen receptor-responsive element (ERE) in their
promoter region) and indirectly (via steroid biosynthesis-related
genes at gonadal level). The histopathological results veriﬁed the
highly potent masculinizing effect of fadrozole in this study, with
99% males already at the lowest fadrozole concentration of 10 g/L
(Fig. 1B–D). It also indicated a more rapid maturation of the gonads.
The average maturity index of the male gonads increased from
approximately 2.0 in the control groups to approximately 2.7 at
the highest fadrozole concentration (Fig. 1C). A promoting effect
on the maturity index of zebraﬁsh was described by Baumann
et al. (2013) also for other masculinizing substances. This observa-
tion underpins the assumption that aromatase inhibition elevates
levels of androgen and in turn, stimulates testis maturation. Fur-
ther strengthening evidence is provided e.g., by Seki et al. (2006),
who reported elevated gonadosomatic indices, and Morthorst et al.
(2010), who  reported a stimulating effect on testis maturation in
zebraﬁsh after exposure to 17ß-trenbolone (a strong androgen).
However, particular attention of the study was directed to the
gene expression endpoints. Even though mRNA synthesis does
not unequivocally result in protein expression (i.e. translation of
transcribed genes, compare Nikinmaa and Rytkönen, 2011), tran-
scription level changes can serve as measurable markers in the
cascade form the initial event to effect manifestation at organism
level. Thus, transcription of selected genes involved in regula-
tory events of hypothalamus-pituitary-gonadal (HPG) signaling,
steroidogenesis, steroid signaling, and signaling responses was
analyzed at key developmental stages during early life (48 hpf, 96
hpf) and early (28 dpf) and late puberty (63 dpf). Five of the 28
selected genes showed signiﬁcant regulation by fadrozole at more
than one concentration and time point and were therefore consid-
ered promising candidates for biomarkers of aromatase inhibition.
These genes are igf1, star, lss,  cyp19a1b and vtg1. The correspond-
ing proteins are involved in the regulation of transcription factors,
steroid/terpenoid synthesis, cholesterol transport, and direct reg-
ulation of expression by estradiol (see Fig. 6).
Signiﬁcant responses to fadrozole were not restricted to these
genes but the discussion primarily focuses on these genes in terms
of their function as biomarkers for the identiﬁcation of endocrine
disruptive properties of tested substances. In order to put the tran-
scriptional changes caused by aromatase inhibition into a broader
perspective, also the role of the corresponding proteins in steroido-
genesis was contemplated. Alterations at the transcription level
often results in changes at the translational level, even though post-
transcriptional processing and regulation disallow a one-to-one
transfer from transcription to translation (Nikinmaa and Rytkönen,
2011).
The vtg1 gene is a well-established estrogenic biomarker
(Muncke and Eggen, 2006) as it contains an ERE in its promoter
region. In addition, vtg1 is expressed at reliably measurable mRNA
and protein levels in adult zebraﬁsh only in females (Wang et al.,
2005). The differential transcription of vtg1 in control ﬁsh at 63
dpf was  interpreted as sexually dimorphic analogue to the VTG
protein. Therefore, the division into high and low vtg1 mRNA lev-
els of controls at 63 dpf, allowed us to perform a differential
sex-related analysis of the other genes without the knowledge of
the histopathological sex of these ﬁsh. Thus, the results obtained
for fadrozole-treated ﬁsh discerned genes that were signiﬁcantly
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Fig. 6. Role of the selected biomarker genes within the steroid biosynthesis path-
way. Fadrozole exposure (pink star) directly inhibited the activity of the aromatase
and subsequently also of cyp19a1b (and the other isoform cyp19a1a; not shown).
The conversion of testosterone to estradiol (E2) is inhibited and the decrease in E2
directly lowers the transcription of the ERE-responsive genes vtg1, and cyp19a1b.
Aromatase inhibition also has a stimulating effect on the steroid biosynthesis affect-
ing  key steps, e.g. IGF-R signaling, the synthesis of fatty acids to cholesterol or the
cholesterol transport to the inner membrane of the mitochondrion. The genes igf1,
lss,  and star are involved and respond either already early (igf1) or later during
puberty (lss and star) with up-regulation. In contrast to the ERE-responsive genes,
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We postulate that the transcription of these genes is applicable asegulation of these genes is subject to mostly indirect control mechanisms, which
omplicates the prediction of expression changes.
hanged compared to putative females as differentially expressed
ue to sex. Genes that were signiﬁcantly changed compared to
oth control groups, suggested their involvement in a fadrozole
elated but sex independent steroid biosynthesis dysregulation.
xpression of vtg1 mRNA in the fadrozole exposed ﬁsh showed
own-regulation already in the early developmental stages (48/96
pf, Fig. 2), which was not surprising since the estrogen respon-
iveness of vtg1 in zebraﬁsh embryos as early as 48 hpf was known
rom previous estrogenic exposures (Schiller et al., 2014, 2013b).
t 63 dpf, vtg1 showed a strong down-regulation versus the high
tg1 control group, and no regulation compared to the low vtg1
ontrol group, likely due to the difference in estrogen levels and
onsequently, in VTG concentrations in females and males. This
esult is consistent with results of histopathology showing that
lmost all fadrozole-treated ﬁsh were morphologically identiﬁed
s males. Moreover, these results are in line with the in AOP of
romatase inhibition established in adult females in which vtg1
own-regulation at mRNA and protein level was identiﬁed as KE.
Similar to vtg1, transcription of cyp19a1b is controlled by an
RE in its promoter region. Accordingly, its mRNA level was signiﬁ-
antly down-regulated, as it was anticipated for genes requiring the
inding of estrogen-bound estrogen receptors for activation. Aro-
atase inhibition leads to reduced estrogen levels, thus inhibitinghe expression of ERE-possessing genes. Transcriptional regulation
f these genes by aromatase inhibitor treatment or other estro-
enic disruptors has been described for ﬁsh in several studies (Filbycology 176 (2016) 116–127 125
et al., 2007; Heppell et al., 1995; Schiller et al., 2014; Wang et al.,
2010). Quantiﬁcation of mRNA of ERE-controlled genes can thus be
considered a direct marker of aromatase inhibition in pubescent
zebraﬁsh.
The proposed marker gene igf1 showed a concentration-
dependent increase in mRNA expression at all investigated time
points (compare Figs. 2–4), although the up-regulation was sig-
niﬁcant only at early developmental stages (48/96 hpf). The IGF1
protein is related to the growth hormone (GH)/insulin-like growth
factor (IGF) axis, which is essential for normal growth and develop-
ment in vertebrates. For ﬁsh, the expression of igf genes, including
igf1, and subsequent translation into proteins, plays a crucial role in
normal gonadal function, and modulation by estrogenic disruptors
has been postulated (Brown et al., 2011; Reinecke, 2010). Further-
more, it was  shown that Igf1 protein stimulated aromatase activity
and also cyp19a1 gene expression in red sea bream (Kagawa et al.,
2003). In turn, the observed up-regulation of igf1 mRNA in the
present study may  be interpreted as a compensatory mechanism
to the aromatase inhibition of fadrozole. This assumption would
be supported by evidence found for brown trout (Marca Pereira
et al., 2014), demonstrating the up-regulation of igf1 mRNA upon
treatment with prochloraz, an imidazole fungicide known to act as
aromatase inhibitor.
In contrast to igf1, transcription of star was exposure
concentration-dependently up-regulated only at 63 dpf in both
high and low vtg1 expressers. A differential expression of star upon
treatment with EDCs was  already evidenced for early life stage fat-
head minnow and adult goldﬁsh (Johns et al., 2011; Sharpe et al.,
2007). Since StAR protein coordinates cholesterol transport to the
inner mitochondrial membrane, which is a rate-limiting step dur-
ing steroidogenesis (Johns et al., 2011), we  assumed a functional
role of star in maintenance of steroid concentrations in adulthood
rather than during development. The up-regulation of star mRNA
would indicate an increased demand in cholesterol shuttling due to
the stimulation of steroidogenesis caused by the aromatase inhibi-
tion. The up-regulation of star mRNA was equally strong in putative
genetic male and female zebraﬁsh (low and high vtg1 expressers)
and thus, suggested an upstream regulation of star transcription
rather than through the downstream imbalance in estrogen syn-
thesis.
The functional role of the protein lanostyryl synthase dur-
ing steroid biosynthesis is the synthesis of cholesterol from fatty
acids. Together with sc4mol (see Fig. 4), which is involved in the
same key process, the lss gene was found down-regulated early in
development (signiﬁcant at 96 hpf), and up-regulated at 63 dpf.
Positive regulation of lss was  already described for estrogenic and
anti-androgenic substances in 48 hpf zebraﬁsh and 7 dpf medaka
(Schiller et al., 2014). An anti-estrogenic effect of aromatase inhi-
bition in the present study could therefore explain the suppression
of lss transcription at 96 hpf. The up-regulation of lss mRNA at 63
dpf rather signiﬁed a higher demand for cholesterol due to the
stimulation of steroid biosynthesis (in compensation of aromatase
inhibition), which would be expected to be higher in the putative
females.
Four of the ﬁve genes which we  selected as potential biomark-
ers, based on their regulation upon fadrozole treatment at different
developmental stages, were considered potential markers of estro-
genic disruption already earlier. Johns et al. (2011) demonstrated
regulation of igf1, star, vtg1 in embryo and larval fathead minnow
after exposure to estrogenic and anti-estrogenic EDCs. Further-
more, Hao et al. (2013) performed a study with larval zebraﬁsh and
E2 and found regulation of vtg1 and cyp19a1b starting from 4 dpf.additional marker endpoint to facilitate the interpretation of FSDT
results. The veriﬁcation of this hypothesis, however, will require
further investigations involving different EDCs.
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The results of the present study did not only provide valu-
ble ﬁndings on potential gene biomarkers for the FSDT, they also
llowed us to extend the scope of the current AOP of aromatase
nhibition. The existing AOP for aromatase inhibition (Ankley et al.,
010, 2009; aopkb.org/aopwiki/index.php/Aop:25) was  developed
ased on data obtained by Fish Short Term Reproduction Assays
FSTRAs) with fathead minnow. It describes the gonadal aromatase
nhibition in adult females, which results in reduced female fecun-
ity due to reduced VTG synthesis. When transferring this AOP of
romatase inhibition to the sensitive life stage of ﬁsh sexual devel-
pment and gonad maturation, the adverse outcome (AO) changes
o an altered sex ratio. The MIE  of fadrozole exposure during ﬁsh
exual development is the effective inhibition of the P450 aro-
atase (CYP19), which regulates the conversion of C19-androgens
o C18-estrogens (Callard et al., 1978). This conversion is a key event
f the steroid biosynthesis pathway and its inhibition leads to a
eduction of estrogen synthesis and subsequently lowers E2 plasma
evels. In developing zebraﬁsh, this estradiol imbalance promotes
estis differentiation in a concentration dependent manner.
In adult females, the reduction on E2 plasma level impacts
egatively on ERE-regulated genes like vtg1 and cyp19a1b and con-
equently reduces the synthesis of VTG, which in turn diminishes
he oocyte quality and maturation in female ﬁsh as the next key
vent, leading to reproductive dysfunction. Both alternative AOPs
f aromatase inhibition end in declining population trajectories,
ndependent of the developmental stage affected by aromatase
nhibition. The mRNA levels that were identiﬁed to be regulated
t the different life stages, in particular of the directly estrogen reg-
lated genes vtg1 and cyp19a1b,  could represent useful biomarkers
upporting a KE at the molecular level (OECD, 2014). In this way
hey can be integrated into the existing AOP of aromatase inhibition
aopkb.org/aopwiki/index.php/Aop:25).
In conclusion, this study was able to provide further valu-
ble evidence that the implementation of molecular endpoints
n current testing procedures for EDCs can provide a feasible
nd informative tool for the prioritization of EDCs. Moreover, the
dentiﬁcation of additional marker genes for supporting the char-
cterization of the MoAs of endocrine-disrupting chemicals can be
nstrumental in deﬁning new KEs of existing or new AOPs related
o endocrine disruption.
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